Back to Agenda
Session # 2 FUTURISTIC PRECLINICAL DEVELOPMENT – TRENDS AND OPPORTUNITIES
Session Chair(s)
Kiran Marthak, MD, FFPM, FRCP
Director, Phase 1 & Regulatory, Lambda Therapeutic Research Ltd., India
Charu Gautam, MD
Senior Director- Medical Science and Strategy, IQVIA, India
Speaker(s)
CENTRAL ROLE OF DMPK IN DRUG DESIGN AND DEVELOPMENT
Ramachandra Sangana
Senior Investigator, PK Sciences, Novartis, India
ROLE OF GENOMICS AND BIOMARKERS IN DRUG DISCOVERY AND DEVELOPMENT
Pramod Kabra, MD
Director, Healthcare- India and South Asia, Thermofisher, India
Have an account?